• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
[Retracted] MicroRNA‑642a‑5p inhibits colon cancer cell migration and invasion by targeting collagen type I α1.[已撤回]微小RNA-642a-5p通过靶向I型胶原α1抑制结肠癌细胞的迁移和侵袭。
Oncol Rep. 2024 Oct;52(4). doi: 10.3892/or.2024.8795. Epub 2024 Aug 19.
2
[Retracted] LncRNA TTN‑AS1 promotes endometrial cancer by sponging miR‑376a‑3p.[已撤回]长链非编码RNA TTN-AS1通过海绵吸附miR-376a-3p促进子宫内膜癌。
Oncol Rep. 2024 Dec;52(6). doi: 10.3892/or.2024.8820. Epub 2024 Oct 11.
3
[Retracted] MicroRNA‑381 serves as a prognostic factor and inhibits migration and invasion in non‑small cell lung cancer by targeting LRH‑1.[已撤回] 微小RNA-381作为一种预后因素,通过靶向肝受体同源物1抑制非小细胞肺癌的迁移和侵袭。
Oncol Rep. 2023 Nov;50(5). doi: 10.3892/or.2023.8640. Epub 2023 Oct 6.
4
[Retracted] Tetramethylpyrazine inhibits prostate cancer progression by downregulation of forkhead box M1.[已撤回] 川芎嗪通过下调叉头框蛋白M1抑制前列腺癌进展。
Oncol Rep. 2024 Nov;52(5). doi: 10.3892/or.2024.8811. Epub 2024 Sep 20.
5
[Retracted] lncRNA‑u50535 promotes the progression of lung cancer by activating CCL20/ERK signaling.[已撤回] 长链非编码RNA‑u50535通过激活CCL20/ERK信号通路促进肺癌进展。
Oncol Rep. 2024 Oct;52(4). doi: 10.3892/or.2024.8785. Epub 2024 Aug 2.
6
[Retracted] AdipoR1‑mediated miR‑3908 inhibits glioblastoma tumorigenicity through downregulation of STAT2 associated with the AMPK/SIRT1 pathway.[已撤回] 脂联素受体1介导的miR-3908通过下调与AMPK/SIRT1途径相关的STAT2抑制胶质母细胞瘤的致瘤性。
Oncol Rep. 2024 Mar;51(3). doi: 10.3892/or.2024.8697. Epub 2024 Jan 8.
7
[Retracted] miR‑187 inhibits the growth of cervical cancer cells by targeting FGF9.[已撤回] miR-187通过靶向FGF9抑制宫颈癌细胞的生长。
Oncol Rep. 2023 Nov;50(5). doi: 10.3892/or.2023.8632. Epub 2023 Sep 21.
8
[Retracted] MicroRNA-124-3p inhibits the growth and metastasis of nasopharyngeal carcinoma cells by targeting STAT3.[已撤回] 微小RNA-124-3p通过靶向信号转导和转录激活因子3抑制鼻咽癌细胞的生长和转移。
Oncol Rep. 2024 Nov;52(5). doi: 10.3892/or.2024.8807. Epub 2024 Sep 6.
9
[Retracted] Propofol modulates the proliferation, invasion and migration of bladder cancer cells through the miR‑145‑5p/TOP2A axis.[已撤回] 丙泊酚通过miR-145-5p/TOP2A轴调节膀胱癌细胞的增殖、侵袭和迁移。
Mol Med Rep. 2024 Jun;29(6). doi: 10.3892/mmr.2024.13218. Epub 2024 Apr 12.
10
[Retracted] Effects of miR‑138‑5p and miR‑204‑5p on the migration and proliferation of gastric cancer cells by targeting EGFR.[已撤回] miR-138-5p和miR-204-5p通过靶向表皮生长因子受体对胃癌细胞迁移和增殖的影响
Oncol Rep. 2024 Feb;51(2). doi: 10.3892/or.2023.8677. Epub 2023 Dec 8.

[已撤回]微小RNA-642a-5p通过靶向I型胶原α1抑制结肠癌细胞的迁移和侵袭。

[Retracted] MicroRNA‑642a‑5p inhibits colon cancer cell migration and invasion by targeting collagen type I α1.

作者信息

Wang Xiaoguang, Song Zhengwei, Hu Biwen, Chen Zhenwei, Chen Fei, Cao Chenxi

机构信息

Department of Surgery, The Second Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang 314000, P.R. China.

出版信息

Oncol Rep. 2024 Oct;52(4). doi: 10.3892/or.2024.8795. Epub 2024 Aug 19.

DOI:10.3892/or.2024.8795
PMID:39155869
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11338242/
Abstract

Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that certain of the cell invasion assay data shown in Fig. 6B on p. 940, and western blot data featured in Fig. 7B on p. 942, had already appeared in previously published articles written by different authors at different research institutes. Owing to the fact that the contentious data in the above article had already been published prior to its submission to , the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a satisfactory reply. The Editor apologizes to the readership for any inconvenience caused. [Oncology Reports 45: 933‑944, 2021; DOI: 10.3892/or.2020.7905].

摘要

在本文发表后,一位关注此事的读者提醒编辑注意,第940页图6B所示的某些细胞侵袭试验数据以及第942页图7B中的蛋白质印迹数据已出现在不同研究机构的不同作者先前发表的文章中。由于上述文章中的有争议数据在提交给本期刊之前就已经发表,编辑决定将本文从该期刊撤回。已要求作者对这些问题作出解释,但编辑部未收到令人满意的答复。编辑就由此造成的不便向读者表示歉意。[《肿瘤学报告》45: 933 - 944, 2021;DOI: 10.3892/or.2020.7905]